Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 2Phase 1/2 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Colorectal Neoplasms 86Ovarian Neoplasms 33Breast Neoplasms 29Carcinoma, Non-Small-Cell Lung 28Colonic Neoplasms 23Rectal Neoplasms 21Fallopian Tube Neoplasms 17Neoplasms 16Neoplasm Metastasis 13Carcinoma, Hepatocellular 13Glioblastoma 11Lung Neoplasms 10Brain Neoplasms 8Carcinoma, Renal Cell 7Uterine Cervical Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Intestinal Neoplasms 5Gastrointestinal Neoplasms 5Digestive System Neoplasms 5Brenner Tumor 5Recurrence 4Peritoneal Neoplasms 4Glioma 4Carcinoma, Ovarian Epithelial 4Adenocarcinoma of Lung 4Rectal Diseases 3Non-Squamous Non-Small Cell Lung Cancer 3Liver Neoplasms 3Intestinal Diseases 3Gastrointestinal Diseases 3

Interventions

Interferon-alpha 7aldesleukin 6Sunitinib 6Radiotherapy 5Nivolumab 5Doxorubicin 5Vincristine 4Ipilimumab 4Filgrastim 4Dactinomycin 4Chemotherapy, Adjuvant 4Axitinib 4cabozantinib 3Sorafenib 3Everolimus 3Etoposide 3Cyclophosphamide 3temsirolimus 2pembrolizumab 2Ifosfamide 2G250 monoclonal antibody 2Fluorouracil 2Carboplatin 2Bevacizumab 2vitespin 1shark cartilage extract 1pazopanib 1lenvatinib 1glutamic acid diethyl ester 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Kidney Neoplasms × Bevacizumab × Clear all
NCT00072046 2016-07-06

Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

Alliance for Clinical Trials in Oncology

Phase 3 Completed
732 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00631371 2016-04-27

INTORACT

Pfizer

Phase 3 Completed
791 enrolled 11 charts
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡